Kelley Purdom

Kelley Purdom is an accomplished professional with 16 years of experience in clinical trial operations, specializing in study management and monitoring oversight. Currently serving as the Executive Director and Clinical Study Group Lead for Rare Disease at Pfizer, Kelley has previously held various leadership roles within the organization, including Clinical Project Manager and Associate Director. They have consistently demonstrated expertise across multiple therapeutic areas and phases of clinical development while leading high-performing teams and implementing key technologies. Kelley is pursuing a Bachelor of Science in Cellular and Molecular Biology from the University of Michigan.